Phillips Medisize Adds Vectura’s Inhalation Drug Delivery Capabilities
Molex, a parent to Phillips Medisize, closes the acquisition of Vectura Group Ltd.
Molex, a parent to Phillips Medisize, closes the acquisition of Vectura Group Ltd.
Molex, a parent to Phillips Medisize, closes the acquisition of Vectura Group Ltd.
Read MoreThe correction addresses potential risks of aerosol buildup on ventilator flow sensors when using in-line nebulizers.
Read MoreMolex has agreed to acquire Vectura, an inhalation drug delivery company, from Philip Morris, with plans to expand its capabilities in inhaled therapeutics.
Read MoreThe acquisition strengthens Veridian Healthcare’s respiratory device offerings and expands its remote patient monitoring and telehealth product portfolio.
Read MoreRitedose Pharmaceuticals is donating 1 million doses of albuterol sulfate and levalbuterol inhalation solutions to Dispensary of Hope, supporting low-income and chronically ill patients.
Read MoreThe recall affects specific lots of the Volara system single-patient use circuit and blue ventilator adapter assembly due to a potential disconnection issue that could disrupt ventilation.
Read MoreThe inhaled therapy for the maintenance treatment of COPD combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule.
Read MoreDesigned for use in hospital and homecare settings, the small-volume nebulizer delivers treatments in as quick as three minutes.
Read MoreIn RT’s April-May 2024 issue, COPD cases in women are projected to increase at a rate five times higher than in men through 2050. Meanwhile, how can RTs prevent inaccurate spirometry readings in African Americans and reduce unplanned extubations in the NICU/PICU? And why does capnography monitoring remain an underutilized tool?Â
Read MoreThe COPD Foundation Nebulizer Consortium’s statement provides recommendations for preventing the spread of respiratory illnesses in healthcare settings and home environments. Â
Read MoreNICU clinicians reveal best practices and explore the latest advancements in delivering resuscitation, oxygen therapy and aerosol therapy to newborns.
Read MoreIn RT’s August-September 2023 issue, we provide an update on the most commonly prescribed pharmacological therapies for respiratory disorders like COPD and asthma; use of CFTR modulators for cystic fibrosis; And ICU/ED aerosol delivery protocols for asthma.
Read MoreResearchers have developed a new tool to calculate the risk of poor outcomes both post-transplant and during the waiting period.
Read MoreCombining manuka honey and the drug amikacin in a lab-based nebulization formulation improved bacterial clearance of Mycobacterium abscessus from the lungs of cystic fibrosis patients.
Read MoreSeveral new SARS-CoV-2 vaccines that target the respiratory system are in development, including one that uses a vibrating mesh to nebulize drops of vaccine doses.
Read MoreIn RT’s March-April 2022 issue, we go beyond the traditional COPD treatment regimen of pharmaceuticals and supplemental oxygen and explore emerging therapies like targeted lung denervation, lung volume reduction, and endobronchial valves; discuss PICU alarm fatigue and aerosol therapy; and investigate virtual reality simulation.
Read MoreThe US Patent Office issued US Patent No. 11,222,648 to ReddyPort to cover the company’s positive pressure ventilation (PPV) microphone system, nebulizer, and related methods.
Read MoreNebulizing medication for pediatric patients is an effective maintenance therapy for chronic lung conditions like asthma or cystic fibrosis; and yet medication adherence remains a major concern.
Read MoreIn RT’s January-February 2022 issue, we cover advanced practice respiratory therapists (APRTs); recent advancements in bronchoscopy; and acute respiratory distress syndrome and respiratory failure during the COVID-19 pandemic.
Read MoreA self-management intervention involving data-logging nebulizers and behavioral changes led to greater adherence rates in CF patients.
Read MoreThe Asthma and Allergy Foundation has issued a warning of a new and dangerous trend spreading on social media: nebulizing hydrogen peroxide to treat COVID-19.
Read MoreInfection control for clinicians and patients when delivering nebulized medications has become a serious concern in critical care units during the COVID-19 pandemic.Â
Read MoreIs it safe to use nebulizers during a global pandemic spread by respiratory aerosols?
Read MoreAerosoLess Medical recently released the SafetyNebTM, an aerosol delivery device fitted with water-resistant viral filters.
Read More